Amneal Expects 2025 Revenues Of $3B-$3.1B And Adjusted EPS Of $0.65-$0.70 Versus Consensus Of $2.896B And $0.71, Respectively
Benzinga
Feb 28, 2025
2025 Financial Guidance
Full Year 2025 Guidance
Full Year 2024 Actuals
Net revenue
$3.0 billion - $3.1 billion
$2.79 billion
Adjusted EBITDA (1)
$650 million - $675 million
$627 million
Adjusted diluted EPS (2)
$0.65 - $0.70
$0.58
Operating cash flow
$255 million - $285 million
$295 million
Operating cash flow, excluding discrete items (3)
$280 million - $310 million
$348 million
Capital expenditures (4)
Approximately $100 million
$52 million
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.